xRead - Episodic Vertigo (January 2026)

1272 |

15264610, 2024, 10, Downloaded from https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14835 by University Of Michigan Library, Wiley Online Library on [21/10/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

HEADACHE

15. Jones SM, Vijayakumar S, Dow SA, Holt JC, Jordan PM, Luebke AE. Loss of α -calcitonin gene-related peptide ( α CGRP) reduces otolith activation timing dynamics and impairs balance. Front Mol Neurosci . 2018;11:289. 16. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational re search informatics support. J Biomed Inform . 2009;42(2):377-381. 17. Sharon JD, Krauter R, Kirk L, et al. Development and validation of VM-PATHI: vestibular migraine patient assessment tool and handi cap inventory. Otol Neurotol . 2020;41(4):e494-e500. 18. Jacobson GP, Newman CW. The development of the dizzi ness handicap inventory. Arch Otolaryngol Head Neck Surg . 1990;116(4):424-427. 19. Tamber AL, Wilhelmsen KT, Strand LI. Measurement properties of the dizziness handicap inventory by cross-sectional and longitudi nal designs. Health Qual Life Outcomes . 2009;7:101. 20. Rizk HG, Velozo C, Shah S, Hum M, Sharon JD, Mcrackan TR. Item level psychometrics of the dizziness handicap inventory in vestib ular migraine and Meniere's disease. Ear Hear . 2024;45:106-114. doi: 10.1097/AUD.0000000000001405 21. Salviz M, Yuce T, Acar H, Karatas A, Acikalin RM. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized con trolled trial. Laryngoscope . 2016;126(1):169-174. 22. Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a random ized controlled trial. Eur Arch Otorrinolaringol . 2014;271(11):​ 2931-2936. 23. Yuan Q, Liu DL, Yu LS, Zhang QF. Flunarizine in the prophylaxis of vestibular migraine:a randomized controlled trial. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi . 2016;30(10):805-810. 24. Hoskin JL, Fife TD. New anti-CGRP medications in the treatment of vestibular migraine. Front Neurol . 2021;12:799002.

25. Lovato A, Disco C, Frosolini A, Monzani D, Perini F. Monoclonal an tibodies targeting CGRP: a novel treatment in vestibular migraine. Medicina . 2023;59(9):1560. doi:10.3390/medicina59091560 26. Warfvinge K, Edvinsson L. Distribution of CGRP and CGRP recep tor components in the rat brain. Cephalalgia . 2019;39(3):342-353. 27. Luebke AE, Holt JC, Jordan PM, Wong YS, Caldwell JS, Cullen KE. Loss of α -calcitonin gene-related peptide ( α CGRP) reduces the efficacy of the Vestibulo-ocular reflex (VOR). J Neurosci . 2014;34(31):10453-10458. 28. Zhang Y, Zhang Y, Tian K, et al. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine. J Headache Pain . 2020;21(1):72. 29. He W, Long T, Pan Q, et al. Microglial NLRP3 inflammasome ac tivation mediates IL-1 β release and contributes to central sensi tization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation . 2019;16(1):78. 30. Chiao W, Krauter R, Kirk L, Steenerson K, Pasquesi L, Sharon J. Understanding dizzy patients a cross-sectional analysis of atti tudes toward diagnosis, providers, and treatment. Ann Otol Rhinol Laryngol . 2022;131(4):352-359. 31. Phillips J, Mikulec AA, Robinson JM, Skarinsky D, Anderson JJ. Efficacy of intratympanic OTO-104 for the treatment of ménière's disease: the outcome of three randomized, double-blind, placebo-­ controlled studies. Otol Neurotol . 2023;44(6):584-592.

How to cite this article: Sharon JD, Krauter R, Chae R, et al. A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. Headache . 2024;64:1264-1272. doi: 10.1111/head.14835